Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljae019 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Gudrun Salamon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Psychology, Sigmund Freud University Vienna, Austria. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Epidermolysis Bullosa, Psychometrics, Quality of Life. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: DEBRA.
Abstract (Originalsprache)
Background
In contrast to clinical diagnosis via external examination, patient-related outcome measures (PROMs) allow access to patients’ internal perceptions. In the case of epidermolysis bullosa (EB) – a rare disease characterized by a wide variety of symptoms and individual disease courses – it is important to integrate the patient’s perspective into diagnostic processes. The Instrument for Scoring Clinical Outcomes of Research for EB (iscorEB) is an EB-specific measurement tool, combining a clinician score (iscorEB-c) and a patient questionnaire (iscorEB-p).
Objectives
The aim of this study is to establish the iscorEB-p as an independent PROM tool by exploring its psychometric properties.
Methods
Sample-based psychometric testing and evaluation were performed on data collected via a multinational online cross-sectional study.
Results
Data analysis was performed with n = 95 participants across all EB types. The reliability and internal consistency of the iscorEB-p was excellent (α = 0.90). Principal component analysis with a varimax rotation resulted in a two-factor solution, explaining 55.6% of the total variance, with the distinct factors ‘everyday life functioning’ and ‘specific EB symptoms’. Convergent validity was shown by high correlations to the Satisfaction With Life Scale (r = –0.52, P < 0.001), the Quality of Life in Epidermolysis Bullosa questionnaire (r = 0.72, P < 0.001) and the Epidermolysis Bullosa Family Burden of Disease questionnaire (r = –0.73, P < 0.001).
Conclusions
The iscorEB-p is a reliable and valid instrument to assess patient-reported health status of people with EB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Psychology, Sigmund Freud University Vienna, Austria.
- EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
- Pediatric Skin Center, Department of Pediatric Dermatology, University Children's Hospital Zurich, Switzerland.
- Division of Pediatric Dermatology, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
ORCID-Profile: Gudrun Salamon, Sophie Strobl, Ursula Field-Werners, Anja Diem, Agnes Schwieger-Briel, Elena Pope
Förderung
- DEBRA
Zitieren
APA
Salamon, G., Strobl, S., Field-Werners, U., Diem, A., Schwieger-Briel, A., & Pope, E. (2024). Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae019
Vancouver
Salamon G, Strobl S, Field-Werners U, Diem A, Schwieger-Briel A, Pope E. Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae019
BibTeX
@article{Salamon2024,
author = {Salamon, Gudrun and Strobl, Sophie and Field-Werners, Ursula and Diem, Anja and Schwieger-Briel, Agnes and Pope, Elena},
title = {Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljae019}
}
EUVIMED